Lu et al.
2014
Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A
Kasim et al.
2004
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification
Meli et al.
2006
Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead
Sun et al.
2011
c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells
BRPI0312464B8
(pt )
2021-05-25
compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos
BR0315988A
(pt )
2005-09-20
Derivados de diidropirimido[4,5-d]pirimidinona substituìda por amino, sua produção e uso como agentes farmacêuticos
BRPI0410563A
(pt )
2006-06-20
derivados de pirazol-quinazolina processo para sua preparação e seu uso como inibidores de quinase
BR0012352A
(pt )
2002-05-14
Compostos de indazol, pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo, ou sal farmaceuticamente aceitável, composições farmacêuticas, método para o tratamento de uma condição de doença de um mamìfero mediada pela atividade de proteìna cinase e método para modular a atividade de um receptor de proteìna cinase
WO2001053268A3
(en )
2001-12-27
Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation
SV2003001148A
(es )
2003-03-18
Derivados de benzamida tiazol y composciones farmaceuticas para inhibir la proliferacion de celulas, y metodos para su utilizacion ref. no.0097-01-sv
ECSP055858A
(es )
2005-09-20
2-(1h-indazol-6-ilamino)-compuestos benzamidas como inhibidores de la proteinquinasas útiles para el tratamiento de enfermedades oftálmicas
BR0312722A
(pt )
2005-05-10
Derivados de pirazol heterobicìclico como inibidores de qinase
BRPI0517921A
(pt )
2008-10-21
métodos para preparar compostos de indazol
DE60315479D1
(de )
2007-09-20
Pyrimidinamid derivate und deren verwendung
Ciarlantini et al.
2021
Development of an Improved Guanidine‐Based Rac1 Inhibitor with in vivo Activity against Non‐Small Cell Lung Cancer
CN109640970A
(zh )
2019-04-16
具有内皮稳定化活性和抗炎活性的非催化底物选择性p38α特异性MAPK抑制剂及其使用方法
Taşdemir et al.
2015
Synthesis, molecular modeling, and biological evaluation of novel chiral thiosemicarbazone derivatives as potent anticancer agents
NO330888B1
(no )
2011-08-08
Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom
Sang et al.
2025
Role of Mitochondria‐Associated ER in Apoptosis
Abdallah et al.
2025
Discovery of new immunomodulatory anticancer thalidomide analogs: design, synthesis, biological evaluation and in silico studies
Suzuki et al.
2010
Regulation of hyperactivation by PPP2 in hamster spermatozoa
TH68221A
(https= )
2005-04-20
Majirská et al.
2025
Discovery of anticancer indole-based 4, 5-dihydroisoxazole derivative with selectivity toward leukemia cells
TW200502236A
(en )
2005-01-16
Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
Keller et al.
2016
Inhibitory effects of imidazoline receptor ligands on basal and kainic acid-induced neurotoxic signalling in mice